PMC:7242013 / 14759-15310 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
435	143-153	Species	denotes	SARS‐CoV‐2	Tax:2697049
436	333-344	Species	denotes	participant	Tax:9606
437	298-306	Disease	denotes	COVID‐19	MESH:C000657245

Id	Subject	Object	Predicate	Lexical cue	mondo_id
T179	143-147	Disease	denotes	SARS	http://purl.obolibrary.org/obo/MONDO_0005091
T180	298-306	Disease	denotes	COVID‐19	http://purl.obolibrary.org/obo/MONDO_0100096

Id	Subject	Object	Predicate	Lexical cue
T156	0-31	Sentence	denotes	How to Conduct Clinical Trials?
T157	32-163	Sentence	denotes	Both APASL and AASLD recommend using alternative physical distancing processes for study assessments to reduce SARS‐CoV‐2 exposure.
T158	164-422	Sentence	denotes	APASL specifically recommends seeking local regulators and institutional review board approval of the contingency measures during the COVID‐19 pandemic, obtaining trial participant’s consent, and documentation of all deviations from the contingency measures.
T159	423-548	Sentence	denotes	These recommendations align with US National Institutes of Health (NIH) revised guidance for NIH‐supported clinical research.
T160	549-551	Sentence	denotes	10